Cargando…

Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves’ disease

BACKGROUND: Thyrotoxicosis is a cause of secondary osteoporosis. High concentrations of triiodotironine (T3) in Graves’ disease stimulate bone turnover, but it is unclear if euthyroidism will always normalize bone metabolism. Thyrotropin (TSH) is known to affect directly the bone metabolism through...

Descripción completa

Detalles Bibliográficos
Autores principales: Ercolano, Monica A, Drnovsek, Monica L, Silva Croome, Maria C, Moos, Monica, Fuentes, Ana M, Viale, Fanny, Feldt-Rasmussen, Ulla, Gauna, Alicia T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847206/
https://www.ncbi.nlm.nih.gov/pubmed/24020400
http://dx.doi.org/10.1186/1756-6614-6-11
_version_ 1782293564024160256
author Ercolano, Monica A
Drnovsek, Monica L
Silva Croome, Maria C
Moos, Monica
Fuentes, Ana M
Viale, Fanny
Feldt-Rasmussen, Ulla
Gauna, Alicia T
author_facet Ercolano, Monica A
Drnovsek, Monica L
Silva Croome, Maria C
Moos, Monica
Fuentes, Ana M
Viale, Fanny
Feldt-Rasmussen, Ulla
Gauna, Alicia T
author_sort Ercolano, Monica A
collection PubMed
description BACKGROUND: Thyrotoxicosis is a cause of secondary osteoporosis. High concentrations of triiodotironine (T3) in Graves’ disease stimulate bone turnover, but it is unclear if euthyroidism will always normalize bone metabolism. Thyrotropin (TSH) is known to affect directly the bone metabolism through the TSH receptor and TSH receptor antibodies (TRAb) may have an important role in bone turn-over. The aim of our study was to determine, in pre and postmenopausal euthyroidism patients with previous overt hyperthyroidism due to Graves’ disease the bone mineral density (BMD) as well as factors that could affect BMD in each group, including TRAb. METHODS: Cross-sectional, non-interventional study. Fifty-seven patients with previous hyperthyroidism due to Graves’ disease (premenopausal: 30, postmenopausal: 27) that remained euthyroid for at least 6 months prior to study were included and compared with fifty- two matched respective controls. Thyrotoxine (T4), TSH, TRAb and BMD were measured. RESULTS: Only euthyroid postmenopausal patients with a history of hyperthyroidism due to Graves’ disease showed lower whole body BMD than matched controls. The BMD expressed as Z-score was less in whole body and lumbar spine in postmenopausal in relation to premenopausal women with previous overt hyperthyroidism due to Graves’ disease. In the postmenopausal patients, the Z-score of lumbar spine BMD correlated negatively with TRAb (r = −0,53, p < 0.008), positively with the time of evolution of the disease (r = +0.42, p < 0.032) and positively with the time of euthyroidism (r = + 0.50, p < 0.008), but neither with serum T4 nor TSH. In a multiple regression analysis TRAb was the only significant independent variable in relation to lumbar spine BMD (F = 3. 90, p < 0.01). CONCLUSIONS: In euthyroid women with a history of Graves’ hyperthyroidism, BMD was only affected in the postmenopausal group. The negative correlation of Z-score of lumbar spine BMD with TRAb suggests that this antibody may affect the bone metabolism.
format Online
Article
Text
id pubmed-3847206
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38472062013-12-04 Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves’ disease Ercolano, Monica A Drnovsek, Monica L Silva Croome, Maria C Moos, Monica Fuentes, Ana M Viale, Fanny Feldt-Rasmussen, Ulla Gauna, Alicia T Thyroid Res Research BACKGROUND: Thyrotoxicosis is a cause of secondary osteoporosis. High concentrations of triiodotironine (T3) in Graves’ disease stimulate bone turnover, but it is unclear if euthyroidism will always normalize bone metabolism. Thyrotropin (TSH) is known to affect directly the bone metabolism through the TSH receptor and TSH receptor antibodies (TRAb) may have an important role in bone turn-over. The aim of our study was to determine, in pre and postmenopausal euthyroidism patients with previous overt hyperthyroidism due to Graves’ disease the bone mineral density (BMD) as well as factors that could affect BMD in each group, including TRAb. METHODS: Cross-sectional, non-interventional study. Fifty-seven patients with previous hyperthyroidism due to Graves’ disease (premenopausal: 30, postmenopausal: 27) that remained euthyroid for at least 6 months prior to study were included and compared with fifty- two matched respective controls. Thyrotoxine (T4), TSH, TRAb and BMD were measured. RESULTS: Only euthyroid postmenopausal patients with a history of hyperthyroidism due to Graves’ disease showed lower whole body BMD than matched controls. The BMD expressed as Z-score was less in whole body and lumbar spine in postmenopausal in relation to premenopausal women with previous overt hyperthyroidism due to Graves’ disease. In the postmenopausal patients, the Z-score of lumbar spine BMD correlated negatively with TRAb (r = −0,53, p < 0.008), positively with the time of evolution of the disease (r = +0.42, p < 0.032) and positively with the time of euthyroidism (r = + 0.50, p < 0.008), but neither with serum T4 nor TSH. In a multiple regression analysis TRAb was the only significant independent variable in relation to lumbar spine BMD (F = 3. 90, p < 0.01). CONCLUSIONS: In euthyroid women with a history of Graves’ hyperthyroidism, BMD was only affected in the postmenopausal group. The negative correlation of Z-score of lumbar spine BMD with TRAb suggests that this antibody may affect the bone metabolism. BioMed Central 2013-09-11 /pmc/articles/PMC3847206/ /pubmed/24020400 http://dx.doi.org/10.1186/1756-6614-6-11 Text en Copyright © 2013 Ercolano et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Ercolano, Monica A
Drnovsek, Monica L
Silva Croome, Maria C
Moos, Monica
Fuentes, Ana M
Viale, Fanny
Feldt-Rasmussen, Ulla
Gauna, Alicia T
Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves’ disease
title Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves’ disease
title_full Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves’ disease
title_fullStr Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves’ disease
title_full_unstemmed Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves’ disease
title_short Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves’ disease
title_sort negative correlation between bone mineral density and tsh receptor antibodies in long-term euthyroid postmenopausal women with treated graves’ disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847206/
https://www.ncbi.nlm.nih.gov/pubmed/24020400
http://dx.doi.org/10.1186/1756-6614-6-11
work_keys_str_mv AT ercolanomonicaa negativecorrelationbetweenbonemineraldensityandtshreceptorantibodiesinlongtermeuthyroidpostmenopausalwomenwithtreatedgravesdisease
AT drnovsekmonical negativecorrelationbetweenbonemineraldensityandtshreceptorantibodiesinlongtermeuthyroidpostmenopausalwomenwithtreatedgravesdisease
AT silvacroomemariac negativecorrelationbetweenbonemineraldensityandtshreceptorantibodiesinlongtermeuthyroidpostmenopausalwomenwithtreatedgravesdisease
AT moosmonica negativecorrelationbetweenbonemineraldensityandtshreceptorantibodiesinlongtermeuthyroidpostmenopausalwomenwithtreatedgravesdisease
AT fuentesanam negativecorrelationbetweenbonemineraldensityandtshreceptorantibodiesinlongtermeuthyroidpostmenopausalwomenwithtreatedgravesdisease
AT vialefanny negativecorrelationbetweenbonemineraldensityandtshreceptorantibodiesinlongtermeuthyroidpostmenopausalwomenwithtreatedgravesdisease
AT feldtrasmussenulla negativecorrelationbetweenbonemineraldensityandtshreceptorantibodiesinlongtermeuthyroidpostmenopausalwomenwithtreatedgravesdisease
AT gaunaaliciat negativecorrelationbetweenbonemineraldensityandtshreceptorantibodiesinlongtermeuthyroidpostmenopausalwomenwithtreatedgravesdisease